Faculty

	Sahar Bedrood, MD, PhD Ophthalmologist Acuity Eye Group Adjunct Clinical Assistant Professor USC Roski Eye Institute Los Angeles County + USC Medical Center Pasadena, California
	Davinder S. Grover, MD, MPH President Dallas Academy of Ophthalmology Attending Surgeon and Clinician Glaucoma Associates of Texas Dallas, Texas
	Leon W. Herndon Jr, MD Professor of Ophthalmology Chief, Glaucoma Division Duke Eye Center Durham, North Carolina
	Jonathan S. Myers, MD Director, Glaucoma Service Wills Eye Hospital Associate Professor of Ophthalmology Sidney Kimmel Medical College Thomas Jefferson University Philadelphia, Pennsylvania
	Arsham Sheybani, MD Assistant Professor of Ophthalmology Fellowship Director, Glaucoma and Anterior Segment Surgery Residency Program Director, Ophthalmology Washington University in St Louis St Louis, Missouri

Disclosure Policy Statement

It is the policy of New York Eye and Ear Infirmary of Mount Sinai that the faculty and anyone in a position to control activity content disclose any real or apparent conflicts of interest relating to the topics of the educational activity in which they are participating. They are also required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. New York Eye and Ear Infirmary of Mount Sinai is committed to providing its learners with quality CME activities and related materials that promote improvements in healthcare and not the proprietary interests of a commercial interest and, thus, has established policies and procedures in place that identify and resolve all conflicts of interest prior to the execution or release of its educational activities. Full disclosure of faculty/planners and their commercial relationships, if any, follows.

Disclosures

Sahar Bedrood, MD, PhD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; Avellino Labs; Glaukos Corporation; and Santen Inc; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Allergan and Glaukos Corporation.

Davinder S. Grover, MD, MPH, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; MicroOptx; New World Medical, Inc; and Reichert, Inc; Contracted Research: Allergan; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Aerie Pharmaceuticals, Inc; Allergan; Bausch & Lomb Incorporated; New World Medical, Inc; and Reichert, Inc.

Leon W. Herndon Jr, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Alcon; Allergan; Glaukos Corporation; New World Medical, Inc; Ocular Therapeutix, Inc; and Santen Inc; Contracted Research: Ocular Therapeutix, Inc; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Alcon; Allergan; Glaukos Corporation; and New World Medical, Inc; Ownership Interest (Stock options, or other holdings, excluding diversified mutual funds): Sight Sciences.

Jonathan S. Myers, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Aerie Pharmaceuticals, Inc; Allergan; Glaukos Corporation; MicroOptx; and Olleyes Inc; Contracted Research: Aerie Pharmaceuticals, Inc; Allergan; Diopsys, Inc; Glaukos Corporation; Haag-Streit Group; Nicox; Olleyes Inc; and Santen Inc; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Aerie Pharmaceuticals, Inc; and Allergan; Ownership Interest (Stock options, or other holdings, excluding diversified mutual funds): Olleyes Inc.

Arsham Sheybani, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; Glaukos Corporation; Ivantis Inc; and Santen Inc.

New York Eye and Ear Infirmary of Mount Sinai Peer Review Disclosure

Kateki Vinod, MD, has no relevant commercial relationships to disclose.

Editorial Support Disclosures

Erika Langsfeld, PhD; Cynthia Tornallyay, RD, MBA, CHCP; Barbara Aubel; and Michelle Ong have no relevant commercial relationships to disclose.

Disclosure Attestation

The contributing physicians listed above have attested to the following:

1. that the relationships/affiliations noted will not bias or otherwise influence their involvement in this activity;
2. that practice recommendations given relevant to the companies with whom they have relationships/affiliations will be supported by the best available evidence or, absent evidence, will be consistent with generally accepted medical practice; and
3. that all reasonable clinical alternatives will be discussed when making practice recommendations.